Hwan Y. Yoo, Ernesto Molmenti, Paul J. Thuluvath – 30 December 2003 – Previous studies have suggested that moderate donor liver steatosis is associated with an increased incidence of primary graft nonfunction (PGNF), delayed graft function, early graft loss, and retransplantation rates. The objective of our study was to determine the effect of donor body mass index (dBMI), after adjusting for other known confounding variables, on PGNF, early graft failure, retransplantation rate, and patient survival.

Wendy L. Frankel, Jason G. Tranovich, Laura Salter, Ginny Bumgardner, Peter Baker – 30 December 2003 – Macrovesicular steatosis (MaS), fibrosis, and inflammation have been associated with poor graft function after liver transplantation. We evaluated histological variation in livers to determine the optimal number of biopsies to estimate pathological characteristics in livers for transplantation. Specimens from autopsies performed during 3 months in 16‐ to 70‐years‐olds without known liver disease or drug and/or alcohol abuse were examined.

Ashok B. Jain, Bijan Eghtesad, Raman Venkataramanan, Paulo A. Fontes, Randeep Kashyap, Igor Dvorchik, A. Obaid Shakil, Leah Kingery, John J. Fung – 30 December 2003 – Hepatitis C virus (HCV) is currently the most common etiology for liver transplantation (LTx) in the United States. A significant number of patients develop recurrent HCV after LTx. Although there is no completely satisfactory treatment for recurrent HCV, a combination of interferon‐α (INF) and ribavirin remains the most widely used.

James Neuberger – 30 December 2003

Kyung‐Suk Suh, Seong Hoon Kim, Sang Beom Kim, Hyuk‐Joon Lee, Kuhn Uk Lee – 30 December 2003 – The goal of this study was to examine the safety and effectiveness of right lobectomy in living donor liver transplantation (LDLT). From January 1999 to January 2002, 100 cases of LDLT were performed at Seoul National University Hospital; 45 involved right lobectomy (RL), 17 involved extended left lobectomy (ELL), 37 involved left lateral segmentectomy (LLS), and 1 involved right posterior segmentectomy. The outcome of RL was compared with those of other types of hepatectomy.

Ignazio R. Marino, Howard R. Doyle – 30 December 2003

Monika Koch, Peter Banys – 30 December 2003

Raghavakaimal Sreekumar, Deborah L. Rasmussen, Russell H. Wiesner, Michael R. Charlton – 30 December 2003 – Treatment of acute cellular rejection (ACR) is associated with increased viral load, more severe histologic recurrence, and diminished patient and graft survival after liver transplantation for hepatitis C virus (HCV). Recurrence of HCV may be difficult to distinguish histologically from ACR .

M. Susan Mandell, Dennis Lezotte, Igal Kam, Stacy Zamudio – 30 December 2003 – Postoperative ventilation and admission to the intensive care unit (ICU) is the standard of care in liver transplantation and comprises a significant proportion of transplantation costs. Because immediate postoperative extubation has been reported previously in a selected group of liver transplant recipients, we questioned whether this protocol could be extended to a larger group of patients.

Thomas M. Fishbein, Sander Florman, Gabriel Gondolesi, Neal S. LeLeiko, Harold A. Mitty, Allan Tschernia, Stuart S. Kaufman – 30 December 2003 – Late technical complications of composite liver/small bowel transplantation procedures are often complex and have not been well defined. Here we describe the unusual presentation and management of two cases of recurrent thrombocytopenia due to hypersplenism resulting from portacaval shunt stenosis. Both patients presented with portal hypertension late after composite liver/small bowel transplantation.